ARTICLE | Finance
Highlights of weekly biotech stock moves
Regulatory, clinical and other milestones
July 21, 2014 7:00 AM UTC
REGULATORY MILESTONES
Basilea Pharmaceutica AG (SIX:BSLN) was up CHF0.35 to CHF97.90 last week after submitting an MAA to EMA for isavuconazole to treat invasive aspergillosis and invasive mucormycosis (zygomycosis). Partner Astellas Pharma Inc. (Tokyo:4503) submitted an NDA to FDA for the product earlier this month...